Home > Product > APIs > Triptorelin Acetate

APIs

Triptorelin Acetate

[Price Inquiry]
CAT#
10-101-36
Synonyms/Alias
(D-Trp6)-LHRH; Triptorelin Embonate; 6-D-Tryptophan-Luteinizing Hormone-Releasing Factor; AY-25650; AY25650; AY 25650; CL-118532; CL118532; CL 118532; D-Trp-6-LH-RH; Decapeptyl; Decapeptyl Depot; Decapeptyl LP; Decapeptyl Trimestral; GnRH, Trp(6)-; LHRH, Trp(6)-; LHRH, Tryptophyl(6)-; Trelstar; Wy-42462; Wy42462; Wy 42462
CAS No.
57773-63-4 (net), 140194-24-7 (acetate)
Sequence
Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2 acetate salt
M.W/Mr.
1311.46
Molecular Formula
C64H82N18O13
Source
Synthetic
Long-term Storage Conditions
−20°C
Application
Triptoreline as an antineoplastic (hormonal) is currently used in the treatment of prostatic cancer where therapy may be required over months or years. It is also used in the treatment of endometriosis and infertility.
Description
Triptorelin acetate is a potent LHRH agonist. It can result in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis. For most prostate cancers, they need the hormone testosterone in order to grow. Almost all testosterone in men is made by the testicles. Triptorelin stops the testicles from making testosterone. This reduces testosterone levels and may shrink the prostate cancer or stop it growing.
Areas of Interest
Hormonal therapy
Home | Site Map | Contact Us | Resources
Copyright © 2008 - Creative Peptides. All rights reserved.